Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
Open Access
- 6 December 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-15
Abstract
Engagement of Fcγ-receptors triggers a range of downstream signalling events resulting in a diverse array of immune functions. As a result, blockade of Fc-mediated function is an important strategy for the control of several autoimmune and inflammatory conditions. We have generated a hexameric-Fc fusion protein (hexameric-Fc) and tested the consequences of multi-valent Fcγ-receptor engagement inin vitroandin vivosystems.In vitroengagement of hexameric-Fc with FcγRs showed complex binding interactions that altered with receptor density and triggered the internalisation and degradation of Fcγ-receptors. This caused a disruption of Fc-binding and phagocytosis.In vivo, in a mouse ITP model we observed a short half-life of hexameric-Fc but were nevertheless able to observe inhibition of platelet phagocytosis several days after hexameric-Fc dosing. In cynomolgus monkeys, we again observed a short half-life, but were able to demonstrate effective FcγR blockade. These findings demonstrate the ability of multi-valent Fc-based therapeutics to interfere with FcγR function and a potential mechanism through which they could have a sustained effect; the internalisation and degradation of FcγRs.Keywords
This publication has 51 references indexed in Scilit:
- Antigen Cross-Presentation of Immune ComplexesFrontiers in Immunology, 2014
- Targeting the Fc receptor in autoimmune diseaseExpert Opinion on Therapeutic Targets, 2014
- Intravenous immunoglobulin therapy: how does IgG modulate the immune system?Nature Reviews Immunology, 2013
- Deciphering complex protein interaction kinetics using Interaction MapBiochemical and Biophysical Research Communications, 2012
- Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in miceArthritis Research & Therapy, 2012
- The Pathogenesis of Chronic Immune Thrombocytopenic PurpuraSeminars in Hematology, 2007
- Tetramolecular immune complexes are more efficient than IVIg to prevent antibody‐dependent in vitro and in vivo phagocytosis of blood cellsBritish Journal of Haematology, 2004
- Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient miceEuropean Journal of Immunology, 1996
- Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpuraThe Lancet, 1993
- Autoimmune Thrombocytopenia: Detection of Platelet Autoantibodies with the Suspension Immunofluorescence TestBritish Journal of Haematology, 1980